Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.42 is in line with its 1-year average of -1.45, around the middle of its 1-year range (-1.53–-1.37).
2.07% above its 12-month average of -1.45.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 6 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.42
EARNINGS PER SHARE (EPS) AVG TTM
-1.45
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.07%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Heartflow, Inc. Common Stock
Market Cap
$4.52B
Earnings Per Share (EPS)
-1.42
TTM Avg
-1.45
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.47B
Earnings Per Share (EPS)
2.79
TTM Avg
0.85
3Y Avg
0.10
5Y Avg
0.11
Market Cap
$4.66B
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.74
3Y Avg
-1.01
5Y Avg
-1.11
Market Cap
$4.71B
Earnings Per Share (EPS)
0.13
TTM Avg
-0.06
3Y Avg
-0.31
5Y Avg
-0.46
Market Cap
$4.79B
Earnings Per Share (EPS)
-3.43
TTM Avg
-1.80
3Y Avg
-1.89
5Y Avg
-2.15
Market Cap
$4.35B
Earnings Per Share (EPS)
-1.85
TTM Avg
-1.54
3Y Avg
-1.48
5Y Avg
-1.19
Market Cap
$4.21B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.52
3Y Avg
-0.25
5Y Avg
0.00
Market Cap
$4.90B
Earnings Per Share (EPS)
-14.56
TTM Avg
-1.16
3Y Avg
-2.58
5Y Avg
-2.86
Market Cap
$4.88B
Earnings Per Share (EPS)
-0.13
TTM Avg
-3.38
3Y Avg
-5.70
5Y Avg
-8.99
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.52B | -1.42 | -1.45 | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.47B | 2.79 | 0.85 | 0.10 | 0.11 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.66B | -0.41 | -0.74 | -1.01 | -1.11 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.71B | 0.13 | -0.06 | -0.31 | -0.46 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.79B | -3.43 | -1.80 | -1.89 | -2.15 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.35B | -1.85 | -1.54 | -1.48 | -1.19 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.21B | -0.54 | -0.52 | -0.25 | 0.00 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | -14.56 | -1.16 | -2.58 | -2.86 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.88B | -0.13 | -3.38 | -5.70 | -8.99 |
| LivaNova PLC (LIVN)vs › | $4.18B | 3.39 | -1.64 | -1.14 | -2.38 |
Trailing EPS (TTM)
$-1.42
Forward EPS (Est.)
$-0.41
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.37 |
| 2024-12-31 | -1.53 |
